UPDATED May 08, 2024
Companies with a Future performance score of at least 3, ordered by Future performance score.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
STX | UK£0.015 | -11.4% | -79.6% | UK£12.1m | n/a | PS2x | E89.0% | n/a | ||
DXRX | UK£0.97 | -2.0% | 0.5% | UK£82.3m | UK£1.67 | PE13723.4x | E59.5% | n/a | ||
INDV | UK£14.35 | 0.5% | -5.6% | UK£1.9b | UK£24.41 | PE485.3x | E34.7% | 0% | ||
FUM | UK£0.41 | 23.7% | -14.4% | UK£122.7m | UK£1.26 | PS39.6x | E111.8% | n/a | ||
LLAI | UK£0.26 | -8.8% | -52.7% | UK£8.0m | UK£2.20 | PS216.6x | E88.7% | n/a | ||
SAR | UK£0.24 | -11.0% | -80.6% | UK£25.9m | UK£1.76 | PB62.1x | E117.2% | n/a | ||
GNS | UK£18.80 | 8.3% | -28.4% | UK£1.2b | UK£27.78 | PE36.9x | E21.5% | 1.7% | ||
AZN | UK£122.64 | 0.8% | 3.8% | UK£190.1b | UK£133.27 | PE37.5x | E15.9% | 2.0% | ||
OXB | UK£3.35 | 16.7% | -16.7% | UK£335.0m | UK£4.20 | PS3.7x | E101.9% | n/a | ||
APH | UK£0.29 | -13.7% | -56.2% | UK£158.6m | n/a | PB0.6x | E47.8% | 0% | ||
EAH | UK£1.20 | 7.4% | 2.1% | UK£81.3m | UK£1.85 | PB1x | E46.3% | 0% | ||
DPH | UK£38.66 | 0.2% | 32.4% | UK£4.4b | UK£37.59 | PS5.8x | E62.5% | 0% | ||
TRX | UK£0.61 | 0% | 5.2% | UK£43.0m | UK£1.20 | PS1.8x | E133.0% | n/a | ||
GSK | UK£17.74 | 4.0% | 23.5% | UK£72.3b | UK£20.24 | PE16.1x | E11.9% | 3.3% | ||
HIK | UK£19.73 | 2.0% | 6.1% | UK£4.4b | UK£22.93 | PE28.8x | E16.0% | 2.9% | ||
HCM | UK£3.13 | 4.3% | 38.5% | UK£2.7b | UK£4.29 | PE33.1x | E17.5% | n/a | ||
ERGO | UK£13.46 | 0.1% | 3.5% | UK£701.1m | UK£14.34 | PE46.7x | E14.2% | n/a | ||
BVX | UK£0.12 | 0% | -23.3% | UK£9.5m | n/a | PB3.4x | E63.8% | n/a |